A technique developed for isolated canine papillary muscle function in various plasmas; and utility ascertained with plasma containing myocardial depressant factors.
Isolated papillary muscles from young dogs were studied to determine the feasibility of utilizing plasma, without added foam depressants, as a test solution to support muscle function. Diluted canine plasma, undiluted canine plasma, plasma with adjusted protein content, monkey plasma, and plasma containing myocardial depressant factors (MDF) were evaluated. For each test, each papillary muscle served as its own control, with either Krebs-Henseleit solution or a control plasma to establish a basis for evaluation of the test plasma. A technique was implemented to oxygenate the muscle, in plasma, without foam production and to monitor pH continuously. These studies indicated that plasma (diluted, undiluted, or with protein adjustments to accommodate experimental procedural requirements) was a satisfactory test solution. Furthermore, plasma from species unrelated to the dog could be utilized. In utilizing plasma, it was essential to establish or adjust the pH and osmolarity for normal muscle function. These studies with plasma containing MDF indicated that MDF depressed canine papillary muscle function. The Vmax values and Po values were decreased and latency was increased. The effects of MDF in canine papillary muscle preparations were completely reversible in short-term studies (up 10 10 hours' duration).
D000818:Animals; D004285:Dogs; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000187:drug effects / Q000502:physiology*; D009201:Myocardial Depressant Factor / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology*; D010949:Plasma; D012996:Solutions
D009201:Myocardial Depressant Factor; D010455:Peptides; D012996:Solutions